- Corporate Officers - B
- Bernstein Bruce
Insider Trading History of Bernstein Bruce
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Bernstein Bruce since 2016.
This trader's CIK number is 1665472.
At the time of last reporting, Bernstein Bruce was the Officer of Petros Pharmaceuticals, Inc.. (stock ticker symbol PTPI).
Also see all insider trading activities at Petros Pharmaceuticals, Inc..
Note that in the past
Bernstein Bruce also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Xwell, Inc. (XWEL) by Bernstein Bruce
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2022 | XWEL | 55,000 | $27,246 | 40,000 | $51,475 | 0 | $0 |
| 2021 | XWEL | 37,500 | $63,895 | 107,500 | $153,187 | 0 | $0 |
| 2018 | XWEL | 19,601 | $7,676 | 0 | $0 | 0 | $0 |
| 2017 | XWEL | 33,200 | $46,784 | 0 | $0 | 0 | $0 |
| 2016 | XWEL | 32,090 | $68,631 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Neurotrope, Inc. (NTRP) by Bernstein Bruce
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2016 | NTRP | 50,000 | $14,000 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Synaptogenix, Inc. (SNPX) by Bernstein Bruce
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2022 | SNPX | 0 | $0 | 22,500 | $26,370 | 0 | $0 |
Yearly summary of insider trading at Petros Pharmaceuticals, Inc. (PTPI) by Bernstein Bruce
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2023 | PTPI | 0 | $0 | 0 | $0 | 6,050 | $0 |
Insider trading activities at 4 companies by Bernstein Bruce:
1. Xwell, Inc. (XWEL)
2. Neurotrope, Inc. (NTRP)
3. Synaptogenix, Inc. (SNPX)
4. Petros Pharmaceuticals, Inc. (PTPI)
Table 1. Insider trading of Xwell, Inc. (XWEL) by Bernstein Bruce
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2022-12-01 | XWEL | Buy | 33,890 | .43 | 14,572 |
| 2022-11-30 | XWEL | Buy | 16,110 | .41 | 6,524 |
| 2022-03-17 | XSPA | Buy | 5,000 | 1.23 | 6,150 |
| 2022-03-07 | XSPA | Sale | 15,000 | .99 | 14,925 |
| 2022-01-21 | XSPA | Sale | 25,000 | 1.46 | 36,550 |
| 2021-12-15 | XSPA | Buy | 2,500 | 1.67 | 4,165 |
| 2021-12-16 | XSPA | Buy | 30,000 | 1.72 | 51,480 |
| 2021-12-17 | XSPA | Buy | 5,000 | 1.65 | 8,250 |
| 2021-08-19 | XSPA | Sale | 107,500 | 1.43 | 153,187 |
| 2018-05-21 | XSPA | Buy | 9,601 | .43 | 4,176 |
| 2018-05-23 | XSPA | Buy | 10,000 | .35 | 3,500 |
| 2017-08-15 | FH | Buy | 6,500 | 1.14 | 7,377 |
| 2017-08-14 | FH | Buy | 3,000 | 1.14 | 3,431 |
| 2017-05-18 | FH | Buy | 23,700 | 1.52 | 35,976 |
| 2016-11-15 | FH | Buy | 1,960 | 2.35 | 4,606 |
| 2016-11-11 | FH | Buy | 8,000 | 2.19 | 17,552 |
| 2016-09-14 | FH | Buy | 11,430 | 2.10 | 24,003 |
| 2016-09-12 | FH | Buy | 10,700 | 2.10 | 22,470 |
Table 2. Insider trading of Neurotrope, Inc. (NTRP) by Bernstein Bruce
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2016-12-02 | NTRP | Buy | 50,000 | .28 | 14,000 |
Table 3. Insider trading of Synaptogenix, Inc. (SNPX) by Bernstein Bruce
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2022-12-16 | SNPX | Sale | 22,500 | 1.17 | 26,370 |
Table 4. Insider trading of Petros Pharmaceuticals, Inc. (PTPI) by Bernstein Bruce
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2023-04-26 | PTPI | Option Ex | 6,050 | .00 | 0 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Bernstein Bruce
(Officer of Petros Pharmaceuticals, Inc. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.